Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC

Categoria dell'articolo: Original Paper

Pubblicato online: 12 mar 2022

Pagine: 49 - 58

Ricevuto: 14 apr 2018

Accettato: 01 giu 2018

DOI: https://doi.org/10.2478/afpuc-2021-0019

Parole chiave

Nebivolol, Valsartan, Atorvastatin, RP-HPLC, Method development, ICH Guidelines (ICH M10), Validation

© 2021 R. N. Kachave et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.